Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05424406 · ClinicalTrials.gov registry record · NA
Role of Sleep Reactivity in Shift Work Disorder
A NA study of Shift-work Disorder, sponsored by Henry Ford Health System.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT05424406: Recruiting NA study of Shift-work Disorder, sponsored by Henry Ford Health System.
NCT05424406 is a NA study of Shift-work Disorder that is actively recruiting participants, run by Henry Ford Health System. The registered enrollment target is 150 participants, below the 208-participant average among 3 other Shift-work Disorder trials with a reported enrollment target (28% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05424406, a NA study of Shift-work Disorder, is actively recruiting participants, sponsored by Henry Ford Health System.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this project is to test sleep reactivity as an independent cause of Shift Work Disorder (SWD). The primary hypothesis is that those with high sleep reactivity will show persistent SWD symptoms after experimental reduction of circadian misalignment, which will then be mitigated with CBT.
Primary Outcome
Melatonin values will be measured in saliva samples, collected in dim light conditions in a laboratory, to determine circadian phase.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy (CBT)
- BEHAVIORAL Active phototherapy
- BEHAVIORAL Control phototherapy
- BEHAVIORAL Sleep education control
Study Locations (1)
Michigan
- Henry Ford Columbus Medical Center - Novi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2027-10-01 |
| Phase | NA |
What NCT05424406 shows while recruiting
NCT05424406 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 208-participant average among 3 other Shift-work Disorder trials with a reported enrollment target (28% lower).
The record links to 1 condition, with Shift-work Disorder appearing as the primary indexed condition, and to 4 interventions - of which Cognitive Behavioral Therapy (CBT) is the first listed.
NCT05424406 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05424406 about?
NCT05424406 is a clinical study titled "Role of Sleep Reactivity in Shift Work Disorder". The purpose of this project is to test sleep reactivity as an independent cause of Shift Work Disorder (SWD). The primary hypothesis is that those with high sleep reactivity will show persistent SWD symptoms after experimental reduction of circadian misalignment, which will then be mitigated with CB...
What is the current status of trial NCT05424406?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-01-01. Estimated completion is 2027-10-01.
What conditions does trial NCT05424406 study?
This clinical trial studies the following conditions: Shift-work Disorder.
What interventions are being tested in trial NCT05424406?
The interventions under investigation include: Cognitive Behavioral Therapy (CBT) (BEHAVIORAL), Active phototherapy (BEHAVIORAL), Control phototherapy (BEHAVIORAL), Sleep education control (BEHAVIORAL).
Who is sponsoring clinical trial NCT05424406?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05424406 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shift-work Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI